Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh
Tweet
Share
E-mailForte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.42), versus ($0.21) reported last year.
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Ipsen names Mariette Finet to its board of directors
- UBS Upgrades Kyocera (6971:JP) (KYOCY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
